Sebela Pharmaceuticals® Appoints Victor Parker as Chief Commercial Officer
Retrieved on:
Monday, October 24, 2022
Birth, Emory University, Health, Exact Sciences (company), Patient, Gastroenterology, MBA, Executive Committee, Clemson University, Mayo Collaborative Services v. Prometheus Laboratories, Inc., Exact sciences, Colonoscopy, Multimedia, History, Intrauterine device, Oval Office Operations, Company, Sebelas Maret University, CEO, Management, Pharmaceutical industry, Online shopping, Immunology, Rheumatology
ROSWELL, Ga., Oct. 24, 2022 /PRNewswire/ -- Sebela Pharmaceuticals, a US pharmaceutical company with a market leading position in gastroenterology and a focus on innovation in women's health, today announced the appointment of Victor Parker to the position of Chief Commercial Officer.
Key Points:
- ROSWELL, Ga., Oct. 24, 2022 /PRNewswire/ -- Sebela Pharmaceuticals, a US pharmaceutical company with a market leading position in gastroenterology and a focus on innovation in women's health, today announced the appointment of Victor Parker to the position of Chief Commercial Officer.
- Mr. Parker will be responsible for Sebela's overall commercial strategy and execution and will serve on Sebela's Executive Committee.
- "I am delighted to announce the appointment of Victor (Vic) Parker as Sebela's new Chief Commercial Officer.
- We are delighted to welcome Vic to the Sebela team," said Alan Cooke, President, and CEO of Sebela Pharmaceuticals.